会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • A BIOCOMPATIBLE DENATURED STARCH SPONGE MATERIAL
    • BIOKOMPATIBLES SCHWAMMMATERIAL MIT DENATURIERTERSTÄRKE
    • EP2233157A1
    • 2010-09-29
    • EP08862032.3
    • 2008-12-08
    • Ji, Xin
    • Ji, Xin
    • A61L15/28A61K31/715
    • A61L15/28A61L15/58A61L26/0023A61L26/0085C08L3/04
    • The present invention relates to a biocompatible modified starch hemostatic sponge/foam and its new use as any of the hemostat, anti-adhesion material, promoting tissue healing material, surgical sealant and tissue adhesive glue. The said modified starch includes any or a composite of more than one of the pregelatinized starch, acid modified starch, oxidized starch, esterified starch, etherized starch, cross-linked starch, and grafted starch, composite modified starch.
      The said hemostatic sponge/foam in this patent is made from modified starch, or a combination of modified starch with other biocompatible hemostat, blood coagulants, plasticizer etc. via vacuum freeze drying process. The advantages of the modified starch hemostatic foam/sponge include 1) multimodality - it can be applied directly to bleeding wound site; 2) having super biocompatibility which can minimize the risks of anaphylaxis, wound infection and wound healing retardation resulting from applying other animal/human components derived hemostats; 3) having super adhesive properties following water absorption which can create the adhesive matrix of clot to adhere and seal the bleeding vessels and wound tissue in particular when profuse bleeding.
    • 本发明涉及一种生物相容性改性淀粉止血海绵/泡沫及其作为任何止血剂,抗粘连材料,促进组织愈合材料,手术密封剂和组织粘合剂胶的新用途。 所述改性淀粉包括预胶化淀粉,酸改性淀粉,氧化淀粉,酯化淀粉,醚化淀粉,交联淀粉和接枝淀粉,复合改性淀粉中的多于一种的任何或复合物。 该专利中所述的止血海绵/泡沫由改性淀粉,或经由真空冷冻干燥法与改性淀粉与其它生物相容性止血剂,凝血剂,增塑剂等组合而成。 改性淀粉止血泡沫/海绵的优点包括1)多模态 - 可直接应用于出血部位; 2)具有超级生物相容性,可以最大限度地减少因施用其他动物/人类成分而产生的止血剂引起的过敏反应,伤口感染和伤口愈合延迟的风险; 3)在吸水后具有超级粘合性能,其可以产生凝块的粘合剂基质,以粘附并密封出血血管和伤口组织,特别是当大量出血时。
    • 5. 发明公开
    • INTERNAL DRY POWDER DELIVERY SYSTEM AND METHOD THEREOF
    • VERFAHRENDAFÜR的INTERNES TROCKENPULVERFREISETZUNGSSYSTEM
    • EP2680912A4
    • 2015-08-19
    • EP11859709
    • 2011-03-21
    • JI XIN
    • JI XIN
    • A61M11/00A61B17/12A61M13/00A61M15/00A61M31/00
    • A61M13/00A61B17/00491A61B2017/00893A61M11/007A61M11/008A61M15/0016A61M2202/064B05B11/062
    • An internal dry powder delivery system through a working channel of an endoscopic cannula for directly applying the powder form medication to an internal tissue/organ site, includes an elongated tubular delivery channel and a powder supply device for producing pressurized gas mixing with the dry powder for feeding to form a mixture of dry powder and pressurized gas delivering to an internal tissue/organ site through the delivery channel via endoscopic cannula. It ensures a smooth powder release by preventing liquid from accumulation at the tip of the delivery channel and offers physicians a new powder form drug delivery method via endoscope. Also, it offers new minimal invasive application by directly and precisely applying the powder format drug to the internal sites of human gastrointestinal organ via endoscope to achieve hemostasis, anti-inflammation, anti-ulcer and anti-tumor treatment, etc.
    • 通过内窥镜套管的工作通道的内部干粉递送系统,用于将粉末形式的药物直接施加到内部组织/器官部位,包括细长的管状递送通道和用于产生与干粉混合的加压气体的粉末供应装置, 进料以形成通过内窥镜插管通过输送通道输送到内部组织/器官部位的干粉和加压气体的混合物。 通过防止液体在输送通道的尖端积聚,确保粉末释放光滑,并通过内窥镜向医生提供新的粉末形式的药物输送方法。 此外,通过内窥镜直接精确地将粉末形式药物直接应用于人体胃肠器官的内部位置,实现止血,抗炎,抗溃疡,抗肿瘤治疗等功能,提供了最新的微创应用。
    • 8. 发明申请
    • MODIFIED STARCH MATERIAL OF BIOCOMPATIBLE HEMOSTASIS
    • 生物化学性质的改良淀粉材料
    • WO2009091549A1
    • 2009-07-23
    • PCT/US2009/000227
    • 2009-01-13
    • STARCH MEDICAL INC.JI, XinXING, ChengSHI, XueshenCHEN, Jianping
    • JI, XinXING, ChengSHI, XueshenCHEN, Jianping
    • A01N43/04A61K31/715
    • A61K31/715A61L24/08A61L26/0023A61L26/0052A61L26/0076A61L31/041A61L31/042A61L2400/04C08L3/04
    • A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.
    • 当作为生物相容性改性淀粉应用于动物组织时,用于生物相容性止血,生物相容性粘附预防,组织愈合促进,可吸收外科伤口密封和组织粘合的改性淀粉材料。 改性淀粉材料产生止血,减少伤口出血,外渗和组织渗出,保持伤口表面或伤口相对湿润或干燥,抑制细菌生长和炎症反应,减少组织炎症,缓解患者疼痛 。 不参与止血活性的任何多余的改性淀粉容易溶解,并在操作期间通过盐水冲洗冲洗掉。 手术伤口治疗后,对伤口,创伤和紧急伤口进行治疗,改性淀粉止血材料被身体快速吸收,无与纱布和绷带去除有关的并发症。